Dr. Reddy's Laboratories Patent-Cliff Exposure & CMS Drug Spending Portfolio

Dr. Reddy's Laboratories (Princeton, NJ): 4 reconciled FDA prescription therapies, $17.6M 2024 CMS Part D & Medicaid spend, and $2,348 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Headquarters / ClusterPrinceton, NJ
Reconciled FDA Portfolio Therapies4
2025 to 2030 Patent-Cliff Revenue Exposure0.0%
Primary Portfolio LOE Date2044-01-01
2024 CMS Total Public Spend$17.6M
2024 Medicare Part D Spend$15.4M
2024 Medicaid Spend$2.3M
California HCAI SB 17 FilingsSpecialty launch notice ($2,348 intro WAC)